Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater

View ORCID ProfileTyson E. Graber, Élisabeth Mercier, Patrick M. D’Aoust, Huy-Dung Hoang, Xin Tian, Syeda Tasneem, Kamya Bhatnagar, Robert Delatolla
doi: https://doi.org/10.1101/2021.02.22.21252041
Tyson E. Graber
1Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada, K1H 8L1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tyson E. Graber
Élisabeth Mercier
2Department of Chemical Engineering, University of Ottawa, Canada, K1N 6N5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick M. D’Aoust
3Department of Civil Engineering, University of Ottawa, Ottawa, Canada, K1N 6N5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huy-Dung Hoang
1Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada, K1H 8L1
4Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada, K1H 8M5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin Tian
3Department of Civil Engineering, University of Ottawa, Ottawa, Canada, K1N 6N5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Syeda Tasneem
3Department of Civil Engineering, University of Ottawa, Ottawa, Canada, K1N 6N5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamya Bhatnagar
3Department of Civil Engineering, University of Ottawa, Ottawa, Canada, K1N 6N5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Delatolla
3Department of Civil Engineering, University of Ottawa, Ottawa, Canada, K1N 6N5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robert.delatolla@uottawa.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed millions of lives globally to date. Rapid accumulation of co-occurring mutations has led to the emergence of viral variants which appear to be more transmissible, virulent, or both. Variants of concern (VOC) now include those belonging to the B.1.1.7, B.1.351, and P.1 lineages. Early detection of VOC and the ability to retrospectively follow their respective, longitudinal prevalence in communities is wanting. Wastewater-based epidemiology (WBE) allows tracking of disease prevalence in the general population using RT-qPCR to detect viral fragments, but ongoing longitudinal studies have yet to differentiate between these variants. Here, we describe and validate a primer extension strategy to amplify and distinguish B.1.1.7-specific, from non-B.1.1.7 alleles by combining new forward, and existing CDC 2019-nCoV_N1 qPCR probes and reverse primers. This assay can be quickly implemented within a current SARS-CoV-2 WBE framework with minimal cost with the goal of providing early detection of increasing B.1.1.7 transmission in a community prior to identification through clinical testing and confirmation via secondary screening strategies. As such, this assay can provide public health units with an additional and much needed metric to be able to rapidly triangulate B.1.1.7 prevalence.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was supported by a CHEO (Children's Hospital of Eastern Ontario) CHAMO (Children's Hospital Academic Medical Organization) grant, awarded to Dr. Alex E. MacKenzie.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The patient specimen used in this study was anonymous and its use was approved by the Ottawa Health Science Network Research Ethics Board (OHSN-REB) under REB 20200235-01H.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 23, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater
Tyson E. Graber, Élisabeth Mercier, Patrick M. D’Aoust, Huy-Dung Hoang, Xin Tian, Syeda Tasneem, Kamya Bhatnagar, Robert Delatolla
medRxiv 2021.02.22.21252041; doi: https://doi.org/10.1101/2021.02.22.21252041
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater
Tyson E. Graber, Élisabeth Mercier, Patrick M. D’Aoust, Huy-Dung Hoang, Xin Tian, Syeda Tasneem, Kamya Bhatnagar, Robert Delatolla
medRxiv 2021.02.22.21252041; doi: https://doi.org/10.1101/2021.02.22.21252041

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1095)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9766)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1557)
  • Health Policy (734)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11639)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1175)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4654)
  • Radiology and Imaging (776)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)